Doctors Perform World's First Remote Stroke Surgery From 200km

A doctor in Santiago, Panama just performed brain surgery on a stroke patient in Panama City without being in the same room, or even the same city.

Dr. Vitor Mendes Pereira controlled a robotic surgical system from 200 kilometers away to remove a blood clot from a stroke patient's brain. The procedure worked flawlessly, with no delays or technical hiccups, marking the first time anyone has performed this type of remote stroke surgery on a human patient.

The technology comes from XCath, a medical robotics company backed by UAE investment, which has been developing its Iris robotic system in collaboration with global medical experts. The company first demonstrated the technology at Abu Dhabi Health earlier this year and just secured $30 million in new funding to bring it to market.

Stroke kills over 5 million people worldwide every year and leaves 80 million living with disabilities. The gold standard treatment, mechanical thrombectomy, involves removing blood clots from the brain, but only 2.79% of people globally can access it. Most stroke patients simply don't live near hospitals with the specialized equipment and trained surgeons needed to perform the procedure.

Time matters desperately in stroke treatment. Patients lose more than 2 million brain cells every minute until doctors remove the clot. The procedure typically needs to happen within a few hours of stroke onset.

The Ripple Effect

Remote robotic surgery could change everything about who gets lifesaving care. Instead of rushing patients to specialized hospitals or waiting for available surgeons, doctors could perform procedures from anywhere in the world. A surgeon in a major medical center could treat patients in rural areas, small towns, or countries without specialized stroke centers.

XCath's system achieved submillimeter precision over a long-distance internet connection, proving the technology works as well remotely as it does in person. The robot is the only one in development that has successfully performed brain procedures and the world's only triaxial neurovascular robot to complete treatment.

Neeraj Agrawal from Crescent Enterprises, which part-owns XCath, says the UAE's investment in medical technology, AI, and robotics created the ecosystem that made this breakthrough possible. "This is truly technology delivered from the UAE to the world," he said.

Dr. Pereira, who performed the surgery, called it a career highlight. The remote procedure matched the simulated surgeries he'd practiced, with imperceptibly low latency that didn't disrupt his surgical workflow at all.

The technology isn't commercially available yet, but XCath is working toward regulatory approval. With $92 million raised since 2017, the company is pushing to make their robotic system the first commercially practical endovascular robot on the market.

Every minute saved in stroke treatment saves brain cells, and every patient who gains access to this surgery gains a chance at life without severe disability.